Exploring the Relationship between the Inhibition Selectivity and the Apoptosis of Roscovitine-Treated Cancer Cells

Abstract EN

The antitumor activity of roscovitine was tested in four cervical carcinoma cells: C33A, HCE-1, HeLa, and SiHa.

The effects of roscovitine on ATP Lite assay, cell cycle, and apoptosis were assessed.

The Sub-G1 DNA content occurred great increasing, and this indicates that apoptosis was induced quickly in HeLa cells, but slowly in the other cells.

The morphological observation results showed that roscovitine induced apoptosis and cell death in the cervical carcinoma cells.

Results revealed that roscovitine exhibited selective cytotoxicity towards 4 cervical carcinoma cells, and the cells showed different morphologic and apoptotic changes at the same concentration.

It was estimated that cervical carcinoma cells responded differently to roscovitine because of differences in apoptotic and genetic background in different cervical carcinoma cells.

This study suggested that roscovitine had the potential to be a chemotherapeutic agent against cervical carcinoma.